# Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency

> **NCT01337752** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 9 (actual)

## Conditions studied

- Multiple Myeloma
- Renal Insufficiency

## Interventions

- **DRUG:** BHQ880
- **DRUG:** BHQ880 Placebo
- **DRUG:** bortezomib
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT01337752
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01337752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01337752, "Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01337752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*